Lodovica Zullo

16PUBLICATIONS
126CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 28, 2026
New Treatment Strategies for Rare Genomic Alterations: EGFR Exon 20 Insertions and HER2-Deregulated Lung Cancer.

|Jul 15, 2026
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.

|Aug 21, 2025
Lung metastases.

Lodovica Zullo, Dimitris Filippiadis, Lizza E L Hendriks

|Apr 16, 2025
BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAFV600E-Mutated Lung Adenocarcinoma.

Pierre de Priester, Lodovica Zullo, Damien Vasseur

|Apr 09, 2025
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.

Seshiru Nakazawa, Federica Pecci, Igor Odintsov

|Aug 29, 2024
Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies.

Pernelle Lavaud, Martina Bortolot, Lodovica Zullo

Pageof 3

Frequent Collaborators

6 joint publications

Marco Tagliamento

6 joint publications

Carlo Genova

5 joint publications

Chiara Dellepiane

5 joint publications

Benjamin Besse